Investor Relations
We have developed a strong portfolio of patented technologies and products for enhancing the health and well-being of humans and animals. Our unique and innovative antimicrobial membrane technologies used in our air filtration products, surgical masks and respirators differentiate us from our competitors in a rapidly growing global market. We are also expanding our line of high quality, cutting-edge, portable animal ultrasound scanners for use in human medicine.
We are committed to becoming a market leader by enhancing our existing technologies and products, designing innovative new applications, licensing production of our antimicrobial products and hand sanitizers to independent partners; and, by expanding our proprietary and partner distributor networks globally.
Recent Press Releases
Noveko | TSX:EKO
| C$ | |
| Daily High/Low | |
| 52 Week High/Low | |
| Market Cap | |
| Shares Outstanding |
Quotes delayed at least 20 mins.
Contact Information
Investor Relations
Gary Mc Cone
Senior Vice-President and Chief Financial Officer
1190, Place Nobel Suite 300
Boucherville, Québec J4B 5L2
Canada
Telephone: 514.875.0606 ext. 312
Telephone: 450.650.1616 ext. 312
Fax: 514.875.0660
gmccone@noveko.com
Transfer Agent
Computershare Investor Services
1500 University Street
Suite 700
Montréal (Québec)
H3A 3S8, Canada
100 University Avenue
9th Floor
Toronto (Ontario)
M5J 2Y1, Canada
Telephone: 514.982.7555
Toll Free: 1.800.564.6253
General Inquires
Click here to contact us